Subscribe
Subscribe
Home Tags Pharmaceutical Industry

Tag: Pharmaceutical Industry

Lobbyists are on track to spend more money this year than any year since 2010.
Healthcare

Lobbying money spikes under President Trump

Washington Examiner -
0
While some people are frightened by the prospect of 3D-printed guns -- including, perhaps, some of the judges in the lower courts here -- that is no reason to allow the government to shut down speech about such guns without ensuring that the restrictions comport with the strictures of the First Amendment.
Healthcare

Files for 3D printed guns are free speech too

Washington Examiner Staff -
0
Sen. Claire McCaskill, D-Mo., announces her findings from an investigation into opioid prescriptions, Wednesday, Sept. 6, 2017, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)
Healthcare

Sen. Claire McCaskill finds Insys inappropriately pushed opioid to patients

Kimberly Leonard -
0
On Wednesday, the Food and Drug Administration approved the first gene therapy in the U.S. called Kymriah, which customize a patient's own immune cells to fight a type of leukemia through a therapy called CAR-T. The drug's maker, Novartis, plans to sell the treatment for $475,000 for the one-time dose. (AP Photo/Andrew Harnik, File)
Healthcare

Revolutionary cancer treatment comes with hefty price tag

Robert King -
0
With Obamacare reform out of the national limelight, for now, Congress should be looking for bold new ideas to make healthcare more affordable. (AP Photo/Patrick Sison)
Beltway Confidential

On prescription drugs, patients must be ‘free to choose’

Casey Given -
0
Mylan has agreed to repay $465 million to the federal government for overbilling for its lifesaving EpiPen allergy antidote. The settlement comes at the end of an investigation that found Mylan avoided paying state Medicaid programs higher rebates for the EpiPen by improperly naming it as a generic medication. (AP Photo/Pablo Martinez Monsivais, File)
Healthcare

Mylan agrees to pay back government $465 million for EpiPen overbilling

Kimberly Leonard -
0
Reps. Elijah Cummings, D-Md., and Peter Welch, D-Vt., sent letters to seven drug makers seeking answers about price hikes for MS drugs. (AP Photo/Pablo Martinez Monsivais)
Healthcare

Democrats accuse multiple sclerosis drugmakers of ‘shadow pricing’

Robert King -
0
Manufacturers did 38 trials for the 22 drugs approved through the FDA's expedited approval process. Of those trials, only 19 were completed within three years. (AP Photo/Gregory Bull)
Healthcare

Speedy drug approvals lacking in follow-up

Robert King -
0
South Carolina is suing the maker of popular painkiller Oxycontin for deceptively marketing the addictive opioid. (AP Photo/Toby Talbot, File)
Healthcare

South Carolina sues Oxycontin maker

Robert King -
0
Martin Shkreli, the drug CEO, said Tuesday that he was told that he was targeted by government authorities because he was too
Crime

Martin Shkreli: I was targeted for being ‘flamboyant and personable’

Pete Kasperowicz -
0
1...109110111...159Page 110 of 159
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA

  • © Copyright 2026. Washington Examiner. All Rights Reserved.